ArticleBiomedicines2022

Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer.

Prakash Gangadaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.